63 related articles for article (PubMed ID: 28209269)
21. Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE
Wang Z; Guo J; Han X; Xue M; Wang W; Mi L; Sheng Y; Ma C; Wu J; Wu X
Cell Biosci; 2019; 9():68. PubMed ID: 31467666
[TBL] [Abstract][Full Text] [Related]
22. Chronic kidney disease measures and the risk of abdominal aortic aneurysm.
Matsushita K; Kwak L; Ballew SH; Grams ME; Selvin E; Folsom AR; Coresh J; Tang W
Atherosclerosis; 2018 Dec; 279():107-113. PubMed ID: 30290962
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease.
Kuo HC; Li SC; Huang LH; Huang YH
Oncotarget; 2017 Sep; 8(37):60875-60891. PubMed ID: 28977831
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin S is associated with degradation of collagen I in abdominal aortic aneurysm.
Klaus V; Schmies F; Reeps C; Trenner M; Geisbüsch S; Lohoefer F; Eckstein HH; Pelisek J
Vasa; 2018 Jun; 47(4):285-293. PubMed ID: 29624112
[TBL] [Abstract][Full Text] [Related]
25. Abdominal Aortic Aneurysm-Associated MicroRNA-516a-5p Regulates Expressions of Methylenetetrahydrofolate Reductase, Matrix Metalloproteinase-2, and Tissue Inhibitor of Matrix Metalloproteinase-1 in Human Abdominal Aortic Vascular Smooth Muscle Cells.
Chan CYT; Cheuk BLY; Cheng SWK
Ann Vasc Surg; 2017 Jul; 42():263-273. PubMed ID: 28288890
[TBL] [Abstract][Full Text] [Related]
26. A potential role for glycated cross-links in abdominal aortic aneurysm disease.
Koole D; van Herwaarden JA; Schalkwijk CG; Lafeber FPJG; Vink A; Smeets MB; Pasterkamp G; Moll FL
J Vasc Surg; 2017 May; 65(5):1493-1503.e3. PubMed ID: 27624703
[TBL] [Abstract][Full Text] [Related]
27. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms.
Carrell TW; Burnand KG; Wells GM; Clements JM; Smith A
Circulation; 2002 Jan; 105(4):477-82. PubMed ID: 11815431
[TBL] [Abstract][Full Text] [Related]
28. Clearance of matrix metalloproteinase-9 is dependent on low-density lipoprotein receptor-related protein-1 expression downregulated by microRNA-205 in human abdominal aortic aneurysm.
Chan CY; Chan YC; Cheuk BL; Cheng SW
J Vasc Surg; 2017 Feb; 65(2):509-520. PubMed ID: 26781079
[TBL] [Abstract][Full Text] [Related]
29. Association of Matrix Metalloproteinase Levels with Collagen Degradation in the Context of Abdominal Aortic Aneurysm.
Klaus V; Tanios-Schmies F; Reeps C; Trenner M; Matevossian E; Eckstein HH; Pelisek J
Eur J Vasc Endovasc Surg; 2017 Apr; 53(4):549-558. PubMed ID: 28209269
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP; Liapis CD
Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
[TBL] [Abstract][Full Text] [Related]
31. The association of genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: a systematic review and meta-analysis.
Morris DR; Biros E; Cronin O; Kuivaniemi H; Golledge J
Heart; 2014 Feb; 100(4):295-302. PubMed ID: 23813847
[TBL] [Abstract][Full Text] [Related]
32. The Role Matrix Metalloproteinases in the Production of Aortic Aneurysm.
Rabkin SW
Prog Mol Biol Transl Sci; 2017; 147():239-265. PubMed ID: 28413030
[TBL] [Abstract][Full Text] [Related]
33. MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.
Li Y; Wang W; Li L; Khalil RA
Life Sci; 2020 Jul; 253():117659. PubMed ID: 32283055
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
